NASDAQ : ELAB
PMGC Holdings Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 2.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.14M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.10M |
| Enterprise Value | -2.62M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 809,579 |
| Shares Outstanding | 809,579 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +997.05% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 3.38% |
| Float | 764,184 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.82 |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.36 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.47 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -105.22% |
| Return on Assets (ROA) | -32.97% |
| Return on Invested Capital (ROIC) | -37.85% |
| Return on Capital Employed (ROCE) | -57.07% |
| Weighted Average Cost of Capital (WACC) | 11.06% |
| Revenue Per Employee | $75,844 |
| Profits Per Employee | -$396,637 |
| Employee Count | 34 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 30,972 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.27 |
| 52-Week Price Change | -99.81% |
| 50-Day Moving Average | 4.05 |
| 200-Day Moving Average | 35.54 |
| Relative Strength Index (RSI) | 25.80 |
| Average Volume (20 Days) | 11,306 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 18,518 |
| Short Previous Month | 27,598 |
| Short % of Shares Out | 2.29% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 0.37 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.58M |
| Gross Profit | -528,822 |
| Operating Income | -12.12M |
| Pretax Income | -13.54M |
| Net Income | -13.49M |
| EBITDA | -11.54M |
| EBIT | -12.12M |
| Loss Per Share | -$99.79 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 18.96M |
| Total Debt | 14.24M |
| Net Cash | 4.73M |
| Net Cash Per Share | $5.84 |
| Equity (Book Value) | 16.74M |
| Book Value Per Share | 27.20 |
| Working Capital | 5.50M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.21M |
| Capital Expenditures | -777,773 |
| Depreciation & Amortization | 574,348 |
| Net Borrowing | 51,883 |
| Free Cash Flow | -8.99M |
| FCF Per Share | -$11.10 |
Margins
| Measure | Value |
|---|
| Gross Margin | -20.51% |
| Operating Margin | -469.96% |
| Pretax Margin | -524.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3,838.11% |
| FCF Yield | -426.88% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 21, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.81 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |